title: FDA approves biosimilar version of infliximab.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D018501:Antirheumatic Agents / Q000737:chemistry / Q000627:therapeutic use; D059451:Biosimilar Pharmaceuticals / Q000737:chemistry / Q000627:therapeutic use; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D006801:Humans; D000069285:Infliximab / Q000737:chemistry / Q000627:therapeutic use; D014481:United States
chemical_list: D018501:Antirheumatic Agents; D059451:Biosimilar Pharmaceuticals; D000069285:Infliximab